A detailed history of Met Life Investment Management, LLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Met Life Investment Management, LLC holds 62,660 shares of PROK stock, worth $103,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,660
Previous 32,871 90.62%
Holding current value
$103,389
Previous $80,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.8 - $2.5 $53,620 - $74,472
29,789 Added 90.62%
62,660 $120,000
Q2 2024

Aug 13, 2024

BUY
$1.44 - $4.2 $47,334 - $138,058
32,871 New
32,871 $80,000
Q2 2023

Apr 29, 2024

BUY
$9.0 - $13.0 $297,846 - $430,222
33,094 New
33,094 $370,000
Q2 2023

Aug 10, 2023

BUY
$9.0 - $13.0 $297,846 - $430,222
33,094 New
33,094 $370,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $102M
More about PROK
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.